MONOCLONAL ANTIBODIES: A REVIEW
Pradnya Deolekar*, Kavitha Dongerkery, Pramila Yadav and Prathmesh Deolekar
Monoclonal antibodies are a relatively new type of "targeted" cancer or biologic therapy. A variety of mechanisms are thought to play important roles in mediating the anti-tumor effects of mAb. These include signaling mediated by cross-linking of surface antigen that leads to cell death, blocking an activation signal that is necessary for continued cell growth, antibody-dependent cellular cytotoxicity (ADCC), complement mediated cytotoxicity (CMC) and the ability of mAb to alter the cytokine milieu or enhance development of an active anti-tumor immune response.
[Full Text Article]